Role of psychosocial reserve capacity in anxiety and depression in patients with systemic lupus erythematosus

Zamora-Racaza, Geraldine; Azizoddin, Desiree R.; Ishimori, Mariko; Ormseth, Sarah R.; Wallace, Daniel J.; Penserga, Ester G.; Sumner, Lekeisha A.; Ayeroff, Julia R.; Draper, Taylor; Nicassio, Perry M.; Weisman, Michael H.

doi:10.1111/1756-185x.13033

Cited by 18 publications

(24 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The calculation of scores was based on previous studies. 14,15,22 The total depression subscale was divided into normal (0-9), mild depression (10)(11)(12), moderate depression (13)(14)(15)(16)(17)(18)(19)(20), severe depression (21-27) and extremely severe depression symptoms (28)(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42). The total anxiety subscale score was divided into normal (0-6), mild anxiety (7-9), moderate anxiety (10)(11)(12)(13)(14), severe anxiety (15)(16)(17)(18)(19) and extremely severe anxiety symptoms (20-42).…”

Section: Measures and Outcomesmentioning

confidence: 99%

“…[25][26][27][28] The 22-item IES-R questionnaire was composed of three subscales that measured mean avoidance, intrusion and hyperarousal. The total IES-R score was multiplied by two and interpreted as normal (0-23), mild psychological impact (24-32), moderate psychological impact (33)(34)(35)(36) and severe psychological impact (>37). Both the DASS-21 and IES-R tools have been previously used for their psychometric properties in research related to the COVID-19 outbreak.…”

Section: Measures and Outcomesmentioning

confidence: 99%

See 1 more Smart Citation

<p>Psychological State and Associated Factors During the 2019 Coronavirus Disease (COVID-19) Pandemic Among Filipinos with Rheumatoid Arthritis or Systemic Lupus Erythematosus</p>

Tee¹,

Salido²,

Reyes³

et al. 2020

OARRR

View full text Add to dashboard Cite

Background: Patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) are perceived to be more vulnerable to worse COVID-19 infection outcome. Furthermore, severe shortage in hydroxychloroquine supply was experienced. Objective: We presented the psychological responses of Filipino SLE and RA patients to the COVID-19 pandemic and shortage of hydroxychloroquine supply. Methods: A total of 512 completed online surveys from SLE and RA patients were gathered from May 19 to 26, 2020. The online survey collected data on socio-demographics, health status, contact history, health service utilization, use of hydroxychloroquine, COVID-19 knowledge and concerns, precautionary measures, information needs, the validated Impact of Events Scale-Revised (IES-R) and Depression, Anxiety and Stress Scales (DASS-21) ratings. Results: The psychological impact of COVID-19 outbreak was at least moderate in 20%. The mean IES-R score was higher among SLE (22.34, SD=14.39) than RA (18.85, SD=13.24) patients. Stress, anxiety and depression were moderate to severe in 12.3%, 38.7%, and 27.7% of respondents. The mean stress subscale score was 10.11 (SD=7.95), mean anxiety subscale score was 6.79 (SD=6.57) and mean depression subscale score was 9.03 (SD=8.77). The risk factors for adverse mental health during the COVID-19 pandemic include the presence of comorbidity of hypertension and asthma; being a healthcare worker; and presence of specific symptoms of myalgia, cough, breathing difficulty, dizziness and sore throat. The protective factors for mental health during the pandemic include satisfaction with available health information and wearing of face masks. Conclusion: In the third month of the pandemic in the Philippines, 20% of the respondents with lupus and RA experienced moderate to severe psychological impact. There was moderate to severe anxiety in 38.7% and moderate to severe depression in 27%. Identification of factors that affect mental health in lupus and RA is useful in implementation of effective psychological support strategies.

show abstract

Section: Measures and Outcomesmentioning

confidence: 99%

Section: Measures and Outcomesmentioning

confidence: 99%

<p>Psychological State and Associated Factors During the 2019 Coronavirus Disease (COVID-19) Pandemic Among Filipinos with Rheumatoid Arthritis or Systemic Lupus Erythematosus</p>

Tee¹,

Salido²,

Reyes³

et al. 2020

OARRR

View full text Add to dashboard Cite

show abstract

“…Socioeconomic status, and factors associated with socioeconomic status, such as reserve capacity and psychological resilience, affect the relationship between depression and anxiety in lupus. [ 10 , 11 ] These diverse findings indicate the depression and anxiety in lupus is likely mediated through a complex mixture of biological, social, economical, and environmental contributors.…”

Section: Introductionmentioning

confidence: 99%

Depression and anxiety in systemic lupus erythematosus

et al. 2018

View full text Add to dashboard Cite

Depression and anxiety cause severe loss of quality of life for patients with systemic lupus erythematosus. The causes and factors that contribute to these psychological manifestations in lupus are difficult to disentangle. This study compared clinical, psychological, and demographic factors between lupus patients, depressed patients, and rheumatoid arthritis patients to discover lupus-specific contributors to depression. Lupus-specific manifestations of depression were also investigated.Physiological, clinical, and psychosocial data were collected from 77 patients. ELISA was used to measure cytokine levels. Univariate and Multivariate analyses were used to compare the patient populations and identify correlations between key physical and psychological indicators.The prevalence of depression in the SLE cohort was 6 times greater than the healthy control subjects. Pain, IL-6, and Pittsburgh Sleep Quality index values were all significantly higher in SLE patients compared with the healthy control group (P < .001, P = .038, and P = .005, respectively). Anxiety levels were significantly higher in SLE patients compared to healthy and RA control patients (P = .020 and .011, respectively). Serum IL-10 concentrations, relationship assessment scale, and fatigue severity scale values were found to be correlated with depression among the SLE patients (P = .036, P = .007, and P = .001, respectively). Relationship assessment and fatigue severity scale scores were found to be the best indicators of depression for the SLE patients (P = .042 and .028, respectively).Fatigue Severity, relationship satisfaction, and IL-10 concentrations are indicators of depression in lupus patients. Despite also suffering from the pain and disability that accompanies chronic autoimmune disease, the rheumatoid arthritis patients had less anxiety and better relationship scores.

show abstract

“…16 Similarly, findings from the aforementioned Moore et al 10 15,17,18 and such factors have been referred to as reserve capacity. 19,20 In the current study, we examined the role of resilience as a potential "psychological reserve" factor 16 that may influence cognition and everyday functioning among individuals with HIV.…”

mentioning

confidence: 99%

Resilience attenuates the association between neurocognitive functioning and everyday functioning in individuals aging with HIV in the Deep South

Fazeli

Moore

Vance

2018

Int J Geriat Psychiatry

View full text Add to dashboard Cite

show abstract

Role of psychosocial reserve capacity in anxiety and depression in patients with systemic lupus erythematosus

Cited by 18 publications

References 48 publications

<p>Psychological State and Associated Factors During the 2019 Coronavirus Disease (COVID-19) Pandemic Among Filipinos with Rheumatoid Arthritis or Systemic Lupus Erythematosus</p>

<p>Psychological State and Associated Factors During the 2019 Coronavirus Disease (COVID-19) Pandemic Among Filipinos with Rheumatoid Arthritis or Systemic Lupus Erythematosus</p>

Depression and anxiety in systemic lupus erythematosus

Resilience attenuates the association between neurocognitive functioning and everyday functioning in individuals aging with HIV in the Deep South

Contact Info

Product

Resources

About